Literature DB >> 10891452

N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements.

J G Noordzij1, N S Verkaik, N G Hartwig, R de Groot, D C van Gent, J J van Dongen.   

Abstract

The proteins encoded by RAG1 and RAG2 can initiate gene recombination by site-specific cleavage of DNA in immunoglobulin and T-cell receptor (TCR) loci. We identified a new homozygous RAG1 gene mutation (631delT) that leads to a premature stop codon in the 5' part of the RAG1 gene. The patient carrying this 631delT RAG1 gene mutation died at the age of 5 weeks from an Omenn syndrome-like T(+)/B(- )severe combined immunodeficiency disease. The high number of blood T-lymphocytes (55 x 10(6)/mL) showed an almost polyclonal TCR gene rearrangement repertoire not of maternal origin. In contrast, B-lymphocytes and immunoglobulin gene rearrangements were hardly detectable. We showed that the 631delT RAG1 gene can give rise to an N-terminal truncated RAG1 protein, using an internal AUG codon as the translation start site. Consistent with the V(D)J recombination in T cells, this N-terminal truncated RAG1 protein was active in a plasmid V(D)J recombination assay. Apparently, the N-terminal truncated RAG1 protein can recombine TCR genes but not immunoglobulin genes. We conclude that the N-terminus of the RAG1 protein is specifically involved in immunoglobulin gene rearrangements.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891452

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  The RAG proteins in V(D)J recombination: more than just a nuclease.

Authors:  M J Sadofsky
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

2.  The C-terminal portion of RAG2 protects against transposition in vitro.

Authors:  Sheryl K Elkin; Adam G Matthews; Marjorie A Oettinger
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

Review 3.  RAG gene defects at the verge of immunodeficiency and immune dysregulation.

Authors:  Anna Villa; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

4.  XLA patients with BTK splice-site mutations produce low levels of wild-type BTK transcripts.

Authors:  Jeroen G Noordzij; Sandra de Bruin-Versteeg; Nico G Hartwig; Corry M R Weemaes; Egbert J A Gerritsen; Eva Bernatowska; Stefaan van Lierde; Ronald de Groot; Jacques J M van Dongen
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

5.  A dual interaction between the DNA damage response protein MDC1 and the RAG1 subunit of the V(D)J recombinase.

Authors:  Gideon Coster; Ayala Gold; Darlene Chen; David G Schatz; Michal Goldberg
Journal:  J Biol Chem       Date:  2012-08-31       Impact factor: 5.157

6.  Role of RAG1 autoubiquitination in V(D)J recombination.

Authors:  Samarendra K Singh; Martin Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

7.  Autoubiquitylation of the V(D)J recombinase protein RAG1.

Authors:  Jessica M Jones; Martin Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

8.  Omenn syndrome with mutation in RAG1 gene.

Authors:  I Cherkaoui Jaouad; K Ouldim; S Ali Ou Alla; Y Kriouile; A Villa; A Sefiani
Journal:  Indian J Pediatr       Date:  2008-11-15       Impact factor: 1.967

9.  AIRE deficiency in thymus of 2 patients with Omenn syndrome.

Authors:  Patrizia Cavadini; William Vermi; Fabio Facchetti; Stefania Fontana; Seiho Nagafuchi; Evelina Mazzolari; Anna Sediva; Veronica Marrella; Anna Villa; Alain Fischer; Luigi D Notarangelo; Raffaele Badolato
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

10.  A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.

Authors:  Jean-Pierre de Villartay; Annick Lim; Hamoud Al-Mousa; Sophie Dupont; Julie Déchanet-Merville; Edith Coumau-Gatbois; Marie-Lise Gougeon; Arnaud Lemainque; Céline Eidenschenk; Emmanuelle Jouanguy; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Françoise Le Deist
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.